Menu

Scientific Publications

AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA

Abstract CT208: Prior vaccination with the autologous Tumor Lysate Particle Loaded Dendritic Cell (TLPLDC) Vaccine may impact clinical outcomes in melanoma patients treated with systemic therapies and re-vaccination; Annelies T. Hickerson, Guy T. Clifton, Tommy A. Brown, Jessica L. Cindass, John W. Myers, Timothy J. Vreeland, Diane F. Hale, Kaitlin M. Peace, Doreen O. Jackson, Garth Herbert, Xianzhong Yu, Thomas E. Wagner and George E. Peoples

 

AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL

Abstract CT150: Initial analysis of open-label administration of autologous tumor lysate (TL) + dendritic cells (DC) vaccine (TLPLDC) in melanoma patients who recurred during a phase IIb adjuvant vaccine trial; Tommy A. Brown, John W. Myers, Tim J. Vreeland, Diane F. Hale, Kaitlin M. Peace, Doreen O. Jackson, Julia M. Greene, Julia M. Greene, John S. Berry, Garth Herbert, Xianzhong Yu, Thomas Wagner, Guy Travis Clifton and George Peoples

 

ASCO Annual Meeting 2018; June 1, 2018; Chicago, IL

Abstract 9525: Interim analysis of a prospective, randomized, double blind, placebo controlled, phase IIb trial of the TLPLDC vaccine to prevent recurrence in resected stage III or IV melanoma patients

John William Myers, Guy T Clifton, Diane F Hale, Tommy A Brown, Timothy J Vreeland, Robert Hans Ingemar Andtbacka, Adam C. Berger, James W. Jakub, Jeffrey J. Sussman, Alicia Maria Terando, Mark B. Faries, George Earl Peoples

 

AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL

Abstract CT036: Early trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in ovarian cancer patients; Kaitlin M. Peace, Timothy J. Vreeland, Guy T. Clifton, Diane F. Hale, Doreen O. Jackson, John S. Berry, Alfred F. Trappey, Garth S. Herbert, Mark O. Hardin, Pauline T. Nichol, Sook L. Yin, Xianzhong Yu, Thomas E. Wagner and George E. Peoples